The Future of theProstate Cancer Diagnostics Market: Growth Trends, Market Size, and Opportunities to Watch
2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
Which Primary Drivers Are Supporting the Continued Market Growth of theProstate Specific Antigen (PSA) Test Market?
The growing incidence of prostate cancer is projected to fuel the advancement of the prostate-specific antigen (PSA) test market. Prostate cancer originates in the prostate gland, a part of the reproductive systems in both males and females. The prostate-specific antigen (PSA) test is widely used to screen for prostate cancer in men. It determines the amount of PSA in the blood, aiding in early detection and risk evaluation. For example, in March 2023, the American Society of Clinical Oncology (ASCO), a professional oncology organization based in the US, reported that an estimated 288,300 men were diagnosed with prostate cancer in the US, and around 34,700 people died in the same year. Consequently, the increasing prevalence of prostate cancer fuels the growth of the prostate-specific antigen (PSA) test market.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12576&type=smp
How Will the Growth Rate of theProstate Specific Antigen (PSA) Test Market Impact Industry Trends by 2034?
The market size of the Prostate Specific Antigen (PSA) test has seen significant expansion in the recent past. The market growth is projected to rise from $4.15 billion in 2024 to $4.66 billion in 2025, yielding a Compound Annual Growth Rate (CAGR) of 12.1%. The upward trend in the historical period is the result of heightened awareness, an ageing population, progress in medical and pharmaceutical fields, and clinical recommendations.
We anticipate a swift expansion in the size of the prostate specific antigen (PSA) test market in the upcoming years. By 2029, it’s projected to increase to a value of $7.29 billion, with a compound annual growth rate (CAGR) of 11.9%. This anticipated growth for the forecast period is thanks to improved test precision, utilisation of a personalised medicine approach, and a globally ageing demographic. Noteworthy trends for the said period comprise a shift towards the combination of biomarkers, technological advancements, testing at the point of care, integration into digital health, plus a focus on prevention and early detection.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12576
How Are Consumer Market Innovations Shaping the Current and Future Landscape of theProstate Specific Antigen (PSA) Test Market?
Innovations in technology are becoming a prominent trend in the prostate-specific antigen (PSA) test market. Major market players are creating cutting-edge screening test tools to maintain their dominance. For example, LynxDx Inc., a diagnostics firm based in the US, rolled out MyProstateScore 2.0 in February 2023, an advanced non-invasive prostatic cancer screening test that uses urine samples. This unique test employs a blend of 18 biomarkers, inclusive of the groundbreaking gene fusion T2:ERG, to provide individualized risk assessments for every patient. Additionally, it provides highly precise, risk stratified insights to guide clinical decisions for patients showing elevated PSA levels or abnormal digital rectal exam (DRE) results. This approach presents significant potential for enhancing prostate cancer screening and treatment.
Who Are the Key Market Players Influencing the Growth of the Corn and Prostate Specific Antigen (PSA) Test Industry?
Major companies operating in the prostate specific antigen (PSA) test market include Siemens AG, F. Hoffmann-La Roche AG, Bayer AG, Abbott Laboratories, Becton Dickinson and Company, PerkinElmer Inc., Beckman Coulter Inc., Bio-Rad Laboratories Inc., Ortho-Clinical Diagnostics Inc., DiaSorin SpA, OPKO Health Inc., R&D Systems Inc., Meso Scale Diagnostics LLC, Tosoh America Inc., Fujirebio Europe N.V., Boditech Med Inc., DRG International Inc., BioVision Inc., Enzo Life Sciences Inc., RayBiotech Inc., Novus Biologicals LLC, Creative Diagnostics Inc., Elabscience, LifeSpan BioSciences Inc., American Laboratory Products Company Ltd., Accuquik Inc.
Order Your Report Now For A Swift Delivery:
Which Key Market Segments Comprise the Prostate Specific Antigen (PSA) Test Market and Drive Its Revenue Growth?
The prostate specific antigen (PSA) test market covered in this report is segmented –
1) By Type: Clinical Laboratory Improvement Amendments (CLIA), Enzyme-Linked Immunosorbent Assay (ELISA), Fluorescence Immunoassay (FIA), Other Types
2) By Application: Screening, Post-Treatment Monitoring, Other Applications
3) By End User: Hospitals, Diagnostic Centers, Research Institutes, Other End Users
Subsegments:
1) By Clinical Laboratory Improvement Amendments (CLIA): CLIA Waived Tests, Non-CLIA Tests
2) By Enzyme-Linked Immunosorbent Assay (ELISA): Sandwich ELISA Kits, Competitive ELISA Kits
3) By Fluorescence Immunoassay (FIA): Point-Of-Care FIA, Laboratory-Based FIA
4) By Other Types: Chemiluminescent Immunoassay (CLIA), Radioimmunoassay (RIA)
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=12576&type=smp
Which Regions Are Emerging as Leaders in the Prostate Specific Antigen (PSA) Test Market?
North America was the largest region in the prostate specific antigen (PSA) test market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the prostate specific antigen (PSA) test market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Browse Through More Reports Similar to the Gobal Prostate Specific Antigen (PSA) Test Maret 2025, By The Business Research Company:
Prostate Cancer Drugs Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/prostate-cancer-drugs-global-market-report
Neoantigen Targeted Therapies Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/neoantigen-targeted-therapies-global-market-report
Testosterone Replacement Therapy Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
